Package | us.nlm.vsac |
Resource Type | ValueSet |
Id | 2.16.840.1.113883.3.1444.3.226 |
FHIR Version | R4 |
Source | http://fhir.org/packages/us.nlm.vsac/https://vsac.nlm.nih.gov/valueset/2.16.840.1.113883.3.1444.3.226/expansion |
URL | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.226 |
Version | 20241128 |
Status | active |
Date | 2024-11-28T01:06:58-05:00 |
Name | LAG3Inhibitor |
Title | LAG 3 Inhibitor |
Realm | us |
Authority | hl7 |
Purpose | (Clinical Focus: The purpose of this value set is to represent concepts of medication LAG 3 Inhibitor.),(Data Element Scope: This value set may use a model element related to Medication.),(Inclusion Criteria: Includes concepts that represent a medication LAG 3 Inhibitor; generic; prescribable; injectable.),(Exclusion Criteria: Excludes concepts that represent non-prescribable branded drugs, components or ingredients.) |
No resources found
CodeSystem | |
rxnorm | RxNorm |
No narrative content found in resource
{ "resourceType": "ValueSet", "id": "2.16.840.1.113883.3.1444.3.226", "meta": { "versionId": "11", "lastUpdated": "2024-11-28T01:06:58.000-05:00", "profile": [ "http://hl7.org/fhir/StructureDefinition/shareablevalueset", "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/computable-valueset-cqfm", "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm" ] }, "extension": [ { "url": "http://hl7.org/fhir/StructureDefinition/valueset-author", "valueContactDetail": { "name": "American Society of Clinical Oncology Author" } }, { "url": "http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate", "valueDate": "2024-11-28" }, { "url": "http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate", "valueDate": "2024-11-28" } ], "url": "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.226", "identifier": [ { "system": "urn:ietf:rfc:3986", "value": "urn:oid:2.16.840.1.113883.3.1444.3.226" } ], "version": "20241128", "name": "LAG3Inhibitor", "title": "LAG 3 Inhibitor", "status": "active", "date": "2024-11-28T01:06:58-05:00", "publisher": "American Society of Clinical Oncology Steward", "jurisdiction": [ { "coding": [ { "system": "urn:iso:std:iso:3166", "code": "US" } ] } ], "purpose": "(Clinical Focus: The purpose of this value set is to represent concepts of medication LAG 3 Inhibitor.),(Data Element Scope: This value set may use a model element related to Medication.),(Inclusion Criteria: Includes concepts that represent a medication LAG 3 Inhibitor; generic; prescribable; injectable.),(Exclusion Criteria: Excludes concepts that represent non-prescribable branded drugs, components or ingredients.)", "compose": { "include": [ { "system": "http://www.nlm.nih.gov/research/umls/rxnorm", "concept": [ { "code": "2596778", "display": "20 ML nivolumab-rmbw 12 MG/ML / relatlimab-rmbw 4 MG/ML Injection" } ] } ] }, "expansion": { "identifier": "urn:uuid:bbb653db-25bf-4703-80db-4766a56644b0", "timestamp": "2025-05-23T21:55:25-04:00", "total": 1, "contains": [ { "system": "http://www.nlm.nih.gov/research/umls/rxnorm", "version": "05052025", "code": "2596778", "display": "20 ML nivolumab-rmbw 12 MG/ML / relatlimab-rmbw 4 MG/ML Injection" } ] } }